Search bioRxiv⌕ Search

Biology subjects

Kabanga, E.

Publications and source records attributed to Kabanga, E..

2 recordsLinked to original sources

Towards Interpretable Multitask Learning for Splice Site and Translation Initiation Site Prediction

In this study, we investigate the effectiveness of multi-task learning (MTL) for handling three bioinformatics tasks: donor splice site prediction, acceptor splice site prediction, and translation initiation site prediction. As the foundation for our MTL approach, we use the SpliceRover model, which has previously been successful in predicting splice sites. While providing benefits such as efficient resource utilization, reduced complexity, and streamlined model management, our findings show that the newly introduced MTL model performs comparably to the SpliceRover model trained separately for each task (single-task models), with a slight decrease in specificity, sensitivity, F1-score, and Matthews Correlation Coefficient (MCC). However, these differences are statistically insignificant (the specificity decreased with 0.0081 for acceptor splice site prediction and the MCC decreased with 0.0264 for TIS prediction), emphasizing the comparable performance of the MTL model. We further analyze the effectiveness of our MTL model using visualization techniques. The outcomes indicate that our MTL model effectively learns the relevant features associated with each task when compared to the single-task models (presence of nucleotides with a higher contribution to donor splice site prediction, polypyrimidine tracts in the upstream of acceptor splice sites, and the Kozak sequence). In conclusion, our results show that the MTL model generalizes well across all three tasks.

bioinformatics↗

Discovering Biomarker Proteins and Peptides for Parkinson's Disease Prognosis Prediction with Machine Learning and Interpretability Methods

Parkinsons disease is a neurodegenerative disorder that affects millions of people worldwide, posing significant challenges for diagnosis and treatment. This study presents a machine learning pipeline for identifying candidate biomarker proteins and peptides from cerebrospinal fluid mass spectrometry (CSF-MS) tests in Parkinsons disease patients. Our pipeline comprises two main stages: (1) model training using mutual information-based feature selection and five different machine learning regressors and (2) identification of candidate biomarkers by combining three types of interpretability methods. Our regression models demonstrated promising effectiveness in predicting the Movement Disorder Society-Unified Parkinsons Disease Rating Scale (MDS-UPDRS) scores, with UPDRS-1 receiving the best predictions, followed by UPDRS-3 and UPDRS-2. Furthermore, our pipeline identified 11 proteins and peptides as potential biomarkers for Parkinsons disease, excluding Levodopa usage which trivially has the most significant impact on the prognosis prediction. Comparisons with four additional pipelines confirmed the effectiveness of our approach in terms of both model performance and biomarker identification. In conclusion, our study presents a comprehensive machine learning pipeline that demonstrates effectiveness in predicting the severity of Parkinsons disease using CSF-MS tests. Our approach also identifies potential biomarkers, which could aid in the development of new diagnostic tools and treatments for patients with Parkinsons disease.

bioinformatics↗